By C L E Katona; Gill Livingston
Read or Download Drug treatment in old age psychiatry PDF
Similar clinical books
A short consultant to accurately settling on and analyzing laboratory exams, Small Animal scientific prognosis by way of Laboratory tools, fifth version is helping you use your in-house lab or your forte reference lab to successfully make exact diagnoses with no working a plethora of pointless and low-yield assessments.
Hugely counseled within the 2006 British scientific organization e-book Awards (Endocrinology)This moment version brings jointly greater than 20 the world over famous specialists within the box to supply a well timed overview of present wisdom. The textual content is still a useful source for all healthcare execs thinking about the care of sufferers who're overweight.
Guide of medical nutrients and Stroke is a accomplished reference on foodstuff for the multidisciplinary crew taking good care of stroke sufferers. concentrating on physicians, nurse practitioners, scientific dietitians, and complicated allied healthiness and clinical scholars, this quantity offers an advent at the types of stroke, linked possibility components, and uniquely featured international views on stroke.
Antiviral chemotherapy has come of age, and, after an preliminary sluggish seasoned gress, the improvement of latest antiviral brokers has proceeded at a extra fast speed and the views for his or her medical use have elevated significantly. Now, 25 years after the 1st antiviral assay (idoxuridine) was once brought within the sanatorium, it truly is becoming to commemorate the start of the antivirals' period.
- Neurological Disorders in Clinical Practice: Case Histories for Medical Students and Residents
- Thyroid Cancer: A Comprehensive Guide to Clinical Management
- Orthodontics - Basic Aspects and Clinical Considerations
- Symposium on Clinical Pharmacology. Biochemical Pharmacology
- Gastrointestinal Oncology: Basic and Clinical Aspects
Additional info for Drug treatment in old age psychiatry
03 02/09/2002 3 14 pm Page 43 Co-morbid depression 43 were not depressed. A study of clomipramine 25–100 mg in patients with dementia and depression or dysthymia found that, although clomipramine had superior efficacy as measured by the response of depressive symptoms, it had a mild adverse effect on cognition. There have been some head-to-head trials of antidepressants in this field. In the first two, groups of patients responded well on depression scales to citalopram 20–40 mg/day and mianserin 30–60 mg/day for 12 weeks.
Most other published trials have lacked placebo control, and there is insufficient RCT evidence for the efficacy of the newer agents, such as SSRIs, in the long-term treatment of depression overall. The exception is citalopram 20–40 mg which in a placebo controlled trial in responders at 8 weeks reduced the rates of recurrence from 68% to 32% over a 48 week period. None of the patients on 20 mg citalopram experienced a recurrence, (Klysner et al, 2001) There is, however, consistent open trial evidence that TCAs and SSRIs have similar prophylactic effects.
Their active drug was the SSRI fluoxetine. The outcome in this study was that the difference in response rates (64% with fluoxetine, 38% with placebo) just failed to reach statistical significance. Post-hoc analyses showed fluoxetine to be significantly superior in those who completed 5 weeks of treatment and in those with more severe physical illnesses. 03 02/09/2002 3 14 pm Page 45 Co-morbid depression 45 depression and heart disease; the mean age of the patients was 70. Response to nortriptyline was significantly better than that to fluoxetine (67% vs 23%).